Post by Unlearn.AI

12,266 followers

#AI isn't just supporting #clinicaldevelopment anymore — it's becoming the infrastructure for how sponsors make decisions. ⚖️ In this interview, Aaron Smith explains how #digitaltwin models connected to patient data and published literature are reshaping trial planning, monitoring, and analysis. He walks through a recent case where historical data from published papers feeds directly into sample size calculations. How AI flags quality issues without unblinding the #trial. Why regulators are pushing back on synthetic-only controls but greenlighting hybrid approaches. If you're navigating #AIcredibility with regulators or wondering what's actually viable in clinical development right now, watch the full interview. https://lnkd.in/g3GEnpWa ——— Fierce Biotech

Post content